Abstract:Objective To construct the recombinant adeno-associated virus vector carrying cancerous inhibitor of PP2A (CIP2A)short hairpin RNA (shRNA)for preparation of high-titer viruses.Methods The small hairpin RNA of CIP2A (CIP2A shRNA)was designed,synthesized and cloned into pDC31 6-EGFP-U6 plasmid which was double digested by Bam HⅠ and Hin dⅢ.The resultant plasmid pDC31 6-EGFP-shRNA was confirmed and served as template to appraise primers.EGFP-CIP2A shRNA sequence was amplified by PCR,double digested with Eco RⅠand Sal Ⅰ and ligated to pSNAV2.0 plasmid digested with the same enzyme pair.pSNAV2.0-EGFP-CIP2A shRNA plasmid DNA was prepared,purified,identified and transfected into BHK-21 cells.BHK-21 cells expressing CIP2A shRNA (BHK-21/CIP2A-shRNA ) were obtained and subsequently infected with VGTC’s proprietary AAV packaging system to package the rAAV2-CIP2A shRNA.After purification,the functional and infectious virus was obtained and the titer of virus was detected.Real-time PCR and Western blot methods were used to detect the expression of CIP2A after infection with HepG2 cells,and the empty viral vector rAAV2-EGFP was used as control. Results A recombinant adeno-associated virus-2 vector carrying CIP2A shRNA was constructed successfully.The presence of the target sequence in the vector was confirmed by double enzyme digestion and sequencing.By transfecting the pSNAV2.0-EGFP-CIP2A shRNA plasmid into BHK-21 cells,BHK-21/CIP2A shRNA cells were infected with helper virus HSV1-rc/ΔUL2 to package the rAAV2-CIP2A shRNA to obtain a functional and infectious virus.The titer of the recombinant virus was 0.25×10 1 2 v.g./mL.The expression of CIP2A mRNA and screening value of 1×10 5 MOI effected HepG2 cells.Conclusion A high-titer recombinant adeno-associated virus-2 vector carrying CIP2A shRNA has been constructed successfully.

Construction of an AFP enhancer-regulated siRNA expression plasmid vector

Cloning of SARS-CoV-S Gene and Construction of Its Short Interfering RNAs Expression Vector

Construction and Identification of Survivin-Targeting Sirna-Expressing Plasmid

Construction and identification of SiRNA recombinant expression vector targeting survivin gene

Construction of a Regulatable Gene Therapy Vector Specific for Hepatocellular Carcinoma

Construction of RNAi Adenoviral Shuttle Vector Targeting Both HIF-1α and Survivin Synchronously

Construction of Eukaryotic Carrier Expression Vector for Apoptosis Inhibiting Gene Survivin siRNA

[Construction of the Recombinant Adenovirus Vector Bearing Dual-Survivin Shrna].

Construction and identification of alpha-fetoprotein antigen epitope modified interleukin-15 lentiviral expression vector

Construction and Expression of Recombined Human AFP Eukaryotic Expression Vector

Construction of Adeno-associated Virus RNA Interference System to Target E2F3 Gene

Construction of a regulable gene therapy vector targeting for hepatocellular carcinoma

Construction and identification of a vector expressing siRNA in mammalian cells

The Construction of Eukaryotic Expression Vector of siRNA Specific for Survivin Gene

Construction of Psuper-H1 RNAi System Inhibiting the Expression of VEGF

Construction of Recombinant Adenovirus Vector Containing Human Survivin Gene and Expression in Fibroblast

Construction, Packaging and Titration of Recombinant Adeno-Associated Virus Vectors Contaning Antitumor Genes

Construction and appraisal of recombinant adeno-associated virus vector for expressing shRNA targeting CIP2A mRNA

Construction of Survivin-Sirna Plasmids and Their Inhibitory Effect on Survivin Gene Expression in Hela Cells

Construct an Adeno Virus Vector Which Has an Aiming Gene 4-1BBL Drived by Survivin Promotor

Construction of recombinant plasmid vector containing human survivin-1 gene and expression in lung adenocarcinoma A549 cells